This prospective, randomized controlled study evaluated the effects of acute hypervolaemic haemodilution (AHH) on the expression of plasma interferoninducible protein-10 (IP-10) and bactericidal/permeability-increasing protein (BPI) in patients undergoing elective total hip replacement. Twenty patients were randomized to receive an infusion of either hydroxyethyl starch (HES group) or lactated Ringer's solution (LR group) immediately after anaesthesia. Plasma concentrations of IP-10 and BPI were measured before anaesthesia (baseline), at the start of surgery, 30 min after the start of surgery and at the end of surgery. Blood loss and the volume of blood transfused were significantly lower in the HES group compared with the LR group. Compared with baseline, IP-10 and BPI concentrations increased significantly in both groups 30 min after the start of surgery. The IP-10 concentrations were significantly lower and BPI concentrations significantly higher in the HES group compared with the LR group 30 min after the start of surgery and at the end of surgery. It is concluded that AHH with HES may be helpful in ameliorating immune function during total hip replacement and in reducing blood loss and the extent of blood transfusion.
Introduction
Colloids are routinely used as plasma volume expanders for treating severe hypovolaemia. Among the artificial colloids, hydroxyethyl starch (HES) is associated with the fewest anaphylactoid reactions and is the *QF Tang and YF Hao contributed equally to this article.
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Acute hypervolaemic haemodilution and IP-10 and BPI expression most commonly used colloid type in clinical practice. 1 Colloids are often used during and after surgery because of their ability to maintain intravascular fluid volume and regional tissue perfusion more efficiently than crystalloids. 2 Pre-operative haemodilution with colloids can help to reduce the effects of surgical blood loss. 3 Acute normovolaemic haemodilution (ANH) is accompanied by removal of autologous blood. A modification of this technique, in which patients are given HES pre-operatively without removal of autologous blood, results in acute hypervolaemic haemodilution (AHH). 4 Clinical studies have shown that injuries and stress caused by surgery are the primary reasons for immune depression during the post-operative period. 5 Anaesthesia can decrease surgery-induced injuries and stress and, therefore, reduce immune depression. 6 The effects of AHH on immune function are, however, unknown.
This prospective, randomized, controlled study aimed to determine the effects of AHH on expression of the chemokines, plasma interferon-inducible protein-10 (IP-10) and bactericidal/permeability-increasing protein (BPI), in patients scheduled for total hip replacement under combined spinal and epidural anaesthesia (CSEA).
Patients and methods

PATIENTS
Patients with an American Society of Anesthesiologists (ASA) physical status I or II who were scheduled to undergo elective total hip replacement with CSEA between January 2008 and January 2009 were randomized into two groups to receive an infusion of either HES (HES group) or lactated Ringer's solution (LR group). Exclusion criteria included anaemia (haemoglobin < 11 g/dl), liver cirrhosis, clinically evident limitations of cardiac or pulmonary function, untreated hypertension, pre-existing renal insufficiency requiring haemodialysis and coagulation disorders. None of the patients had undergone radiotherapy or chemotherapy, or had received immunodepressants before or during surgery. Patients who received antibiotics within 6 h before skin incision or afterwards were excluded from the study.
The study protocol was approved by the Ethics Committee of the Affiliated Suzhou Hospital of Nanjing Medical University, Nanjing, China. Written informed consent was obtained from all the study participants.
ANAESTHESIA AND SURGERY
At 30 min before anaesthesia, 0.1 g phenobarbital sodium and 0.5 mg atropine were injected intramuscularly. After patients were admitted into the operating room, 3 l/min oxygen was given routinely via a nasal catheter.
The CSEA procedure was performed in the same manner in all patients by one of two teams of orthopaedic surgeons. After skin infiltration with 1% procaine, the epidural space was identified at the L2 -L3 vertebral interspace using a 17-gauge Tuohy needle and the loss of resistance to air technique. 7 Using the needle-through-needle procedure, a 25-gauge Whitacre needle was inserted into the subarachnoid space and, after cerebrospinal fluid was obtained, 12 mg hyperbaric 0.75% bupivacaine was injected within 40 s without barbotage. The spinal needle was removed and an epidural catheter was inserted 3 -4 cm into the epidural space. The upper anaesthesia level was determined by measuring the temperature sensation to an alcohol swab in the body midline at 1 min intervals for 10 min after the subarachnoid injection and was maintained at about the sixth thoracic dermatome.
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Immediately after the establishment of anaesthesia, haemodilution was performed: 20 ml/kg LR solution or 20 ml/kg of 6% HES 200/0.5 (mean molecular weight 200 kDa, degree of substitution 0.5; HAES Steril 6%™, Fresenius Kabi, Bad Homburg, Germany) was given to the LR and HES groups, respectively, via a separate venous line at a rate of 50 ml/min using a rapid infusion pump. The intravenous infusion was maintained with Ringer's solution at a rate of 10 ml/min via an infusion pump. Only the anaesthetist administering the infusion was aware of which solution the patient received. Volume therapy was used intra-operatively. Homologous blood was also transfused if the haemoglobin level fell < 9 g/dl.
DETERMINATION OF IP-10 AND BPI CONCENTRATIONS
Venous blood samples were obtained from each patient in tubes containing ethylene diaminetetraacetic acid at four time points: before anaesthesia (baseline), at the start of surgery, 30 min after the start of surgery and at the end of surgery. Plasma concentrations of IP-10 and BPI were measured by enzymelinked immunosorbent assays using commercial kits for human IP-10 (Bender MedSystems ® , Burlingame, CA, USA) and human BPI (USCN Life™, Missouri City, TX, USA), according to the manufacturers' instructions. All samples were analysed at a dilution that resulted in concentrations within the range of the standard curve.
STATISTICAL ANALYSIS
Data were expressed as the mean ± SD or median and range. Statistical analysis was performed using the SAS ® statistical software package, version 9.1 (SAS Institute, Cary, NC, USA) for Windows ® . Biometric data, duration of the operation, blood loss and volume of transfused blood were compared between the two groups using the Mann-Whitney U-test. Comparison of gender between the groups was computed using the χ 2 test. To compare plasma concentrations of IP-10 and BPI, one-way analysis of variance was applied. A P-value < 0.05 was considered to be statistically significant.
Results
A total of 20 patients, aged 45 -73 years and weighing 51 -71 kg were randomized equally to the HES (n = 10) and LR groups (n = 10). There were no significant differences between the two groups with regard to age, weight, ASA physical status or duration of surgery (Table 1 ). Blood loss and the volume of blood transfused were significantly lower in the HES group compared with the LR group (P < 0.01; Table 1 ).
No significant between-group differences were seen in the baseline concentrations of IP-10 and BPI (Table 2) . Compared with baseline values, IP-10 and BPI concentrations were significantly increased in both groups 30 min after the start of surgery and at the end of surgery (P < 0.05). The IP-10 concentrations were significantly lower in the HES group than in the LR group 30 min after the start of surgery (P < 0.05) and at the end of surgery (P < 0.01), whereas BPI concentrations were significantly higher in the HES group than in the LR group 30 min after the start of surgery (P < 0.05) and at the end of surgery (P < 0.01) ( Table 2 ).
Discussion
The AHH procedure has been used for many years as a means of reducing the requirement for homologous blood transfusion during surgery. 8 It is easier, less time-consuming and less expensive than ANH, although some of the work involved with ANH can be done in parallel with other measures. In the present study, 6% HES QF Tang, YF Hao, YN Qian et al. Acute hypervolaemic haemodilution and IP-10 and BPI expression 200/0.5 was chosen because of its excellent safety record and intravascular retention. 1 Immune responses contribute to host defences and are capable of causing tissue injury and disease under pathological conditions. Cellular mediators of innate immune responses, such as macrophages and dendritic cells, are the first line of defence against pathogens and have bidirectional interactions with lymphocytes through cell-surface molecules and secreted cytokines. T-lymphocytes, which are cellular mediators of adaptive immune responses, are functionally classified as CD4 + helper (Th) or CD8 + cytotoxic (Tc) cells and are further subdivided on the basis of the profile of cytokines that they induce on activation. The Th1 and Tc1 cells produce the signature type I cytokine, interferon (IFN)-γ. 9 The differentiation of native CD45RA + T-cells to cytokine-polarized, memory CD45RO + Th1 cells is regulated by the monokine interleukin (IL)-12 and further promoted by IL-18. 10 The Th1 cells preferentially express Before anaesthesia (baseline) 51 ± 11 49 ± 9 5.0 ± 1.1 4.9 ± 1.2 At start of surgery 47 ± 9 45 ± 6 4.7 ± 1.0 4.7 ± 0.9 30 min after start of surgery 77 ± 14 b 63 ± 14 a,c 7.3 ± 1.2 b 8.9 ± 1.6 b,c End of surgery 89 ± 15 b 65 ± 10 b,d 9.9 ± 0.8 b 13.4 ± 1.2 b,d
Data are mean ± SD. a P < 0.05 and b P < 0.01 for within-group comparisons with baseline values; c P < 0.05 and d P < 0.01 for the HES group compared with the LR group. Acute hypervolaemic haemodilution and IP-10 and BPI expression CXC chemokine receptor 3 (CXCR3), which binds three chemokines with high affinity: IP-10 of 10 kDa (also known as CXC ligand 10 [CXCL10]), IFN-inducible T-cell αchemoattractant (I-TAC; also known as CXCL11), and monokine induced by IFN-(Mig; also known as CXCL9). 8, 11 Høgevold et al. 12 reported that concentrations of proinflammatory IL-1β, tumour necrosis factorα (TNF-α) and IL-6 significantly increased during and after total hip replacement. Bactericidal/permeability-increasing protein is a neutrophil-granule protein that exhibits strong antimicrobial activity against Gram-negative bacteria and potently neutralizes the endotoxic activity of purified and bacterial envelope-associated lipopolysaccharide (LPS). 13, 14 It has been shown to be protective against lethal and sub-lethal challenges with Gram-negative bacteria or LPS in a variety of animal models. 15 In a pilot study in eight healthy human volunteers exposed to a single dose of Escherichia coli LPS, BPI not only reduced circulating endotoxin levels but also significantly reduced LPS-triggered mobilization of TNF-α, IL-6, IL-8 and IL-10 and reduced depletion of circulating neutrophils. 14 Many studies have documented the antiinflammatory actions of HES in various pathological conditions. 16 For example, Kaplan et al. 17 demonstrated that HES could attenuate increases in leucocyte adherence and vascular permeability in the cerebral vasculature after global cerebral ischaemia induced by asphyxia, which they suggested might result from the propensity of HES to reduce or modulate the expression of adhesion molecules. Previous studies have also demonstrated that HES can induce down-regulation of inflammatory mediators in the serum and some organs during endotoxaemia. 18, 19 The concentration of IP-10 was increased within 30 min of the start of total hip replacement surgery in the present study, implying that the operation induced significant pro-inflammatory responses.
Haemodilution with HES was found to attenuate this increase in IP-10 concentration, suggesting that HES contributes to the down-regulation of this chemokine and that it could, therefore, have an anti-inflammatory effect. In addition, HES was associated with upregulation of BPI within 30 min of the start of total hip replacement surgery in the present study. Previous studies have shown that BPI is a potent LPS-neutralizing factor produced by polymorphonuclear leucocytes and has an antagonistic effect on LPSbinding protein-related LPS-cell interactions. 20, 21 Hiki et al. 22 reported that significant secretion of BPI during the perioperative period and later in the postoperative period may have a role as an LPSneutralizing mechanism. 22 Using AHH, dilution (lowering the haematocrit) of blood is solely achieved by pre-operative infusion of a plasma expander without the removal of autologous blood. Its efficiency in all surgical disciplines and patient populations has yet to be shown. Haemodilution is only one method, in addition to pre-operative blood donation, automatic auto-transfusion of red blood cells and meticulous surgical haemostasis, of salvaging autologous blood and decreasing the use of homologous blood transfusion with its associated risks. Based on the findings of the present study, AHH with HES may be helpful not only in reducing blood loss and the extent of blood transfusion during total hip replacement, but also in ameliorating immune function. The underlying mechanisms by which HES reduces the expression of IP-10 and increases the expression of BPI are, however,
